RALEIGH, N.C., Jan. 19, 2011 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc. (OTCBB:INOL), a service based healthcare products development, integration and marketing Company, announces today that it has appointed Mr. Wayne Wiggins as Vice President of Advertising. Wayne will be responsible for creating and overseeing all of the Company's public advertising campaigns that will include direct response TV, radio and print advertisements.
Wayne has worked in the film and television industry for over 30 years and is currently the president of Wideshot Productions, Inc. He is the winner of two Emmy Awards; as well as 71 Addy awards for programming, commercial and documentary productions. Wayne spent 16 years with CBS and covered news and all types of sports events, soap operas and special programs. They include the Apollo and Mercury Space Programs and Presidential Campaigns for Jimmy Carter, Ronald Reagan and George H.W. Bush. He also produced the CBS Morning News, the CBS Evening News with Walter Cronkite and numerous major news stories for Sixty Minutes, which included Beirut Bombings, Columbian Cartel Raids, and interviews with Fidel Castro, Pope John Paul and White House Tour with Nancy Reagan.
After leaving CBS, Wayne produced numerous documentaries for the National Geographic Foundation. He also produced the first infomercial in cooperation with Darcy McMannus Advertising and Johnson & Johnson. As President of Wideshot Productions, Wayne produced and directed network television commercials for "Blue Chip" companies such as: Coca Cola, Budweiser, Miller Beer Ford, Carnival Cruise Lines, Sears, Disney, K-Mart, Wendy's and other Fortune 500 companies.
Advertising is a key component to InoLife's goal to achieve mass sales and brand recognition for its consumer based DNA testing products such as the Company's Ancestry DNA product. InoLife is currently in the process of generating a direct response infomercial. Wayne's talent, background and experience in this field will be an integral component to ensure that the finished product will be of the highest quality with maximum results.
"We feel that Wayne Wiggins will be a valuable addition to the Company's management team. With advertising being a key aspect for the success of the Company's current and future DNA-based consumer products, we are confident that Wayne is the right choice for this job," stated Gary Berthold, CEO of InoLife Technologies, Inc.
About InoLife Technologies, Inc.
InoLife is poised to become one of the premier U.S. marketers of state-of-the-art DNA-based test products. Positioned for growth and success in a burgeoning market, InoLife Technologies, www.inolifetech.com, is primarily focused on products, services and solutions that will enable state-of-the-art healthcare for today and the future for a diverse base of customers and end users. The Company's mission is to identify, develop, integrate and bring to market innovative healthcare-based products and services that provide timely and practical solutions. The primary products and services that InoLife is currently addressing focuses upon those specific products and services that provide key solutions through the innovative use of specific DNA testing and Genetic analysis systems.
The principal customers of InoLife's products and services are healthcare providers, physicians, practitioners, hospitals and outpatient facilities. InoLife will be marketing and distributing its products through traditional distribution channels. Additionally, InoLife has developed certain products that can be sold directly to consumers and has created specific programs to reach those customers including e-commerce, direct sales, healthcare providers, pharmacies, distributors, retail sellers and specialty retailers.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.
CONTACT: Henry Harrison IR Pro 2.0, Inc. 407-862-5151 firstname.lastname@example.org www.irprpro.com